Osteri™
Brand Name: Osteri™
Composition: Each pre-filled pen contains 600 mcg of Teriparatide.
Product Description
Medical Info
Osteri is a specialized prescription medicine manufactured by Emcure Pharmaceuticals containing Teriparatide, a recombinant human parathyroid hormone analogue. Supplied as a pre-filled, fixed multi-dose disposable pen device, it is indicated for the treatment of advanced osteoporosis in men and postmenopausal women carrying a high risk of bone fractures. Unlike standard therapies that merely retard bone depletion, Osteri functions as an anabolic agent by actively stimulating osteoblast function to rebuild skeletal infrastructure. This action increases bone mineral density and significantly lowers fracture incidence. It is intended strictly for subcutaneous administration under formal clinical guidance.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
